3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: no lymph node dissection.
- Who it may be relevant to
- Registry conditions: Endometrial Cancer. Basic parameters: from 19 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Three-year Recurrence Free Survival in Patients With Ultra-low-risk Endometrial Cancer Who do Not Undergo Lymph Node dissEction
Overview
To verify the safety of omission of lymph node dissection in ultra-low-risk endometrial cancer (KGOG criteria), we examine the survival of women with ultra-low-risk endometrial cancer who do not undergo lymph node dissection
Interventions
- Procedure no lymph node dissection
do not undergo lymph node dissection
Primary outcome measures
- 3 year recurrence free survival [Time frame: 3 year since surgery]
Secondary outcome measures (10)
- 5 year recurrence free survival [Time frame: 5 year since surgery]
- 5 year overall survival [Time frame: 5 year since surgery]
- surgery time [Time frame: surgery visit]
- change of Functional Assessment of Cancer Therapy - General (FACT G) score from baseline [Time frame: baseline - 1week - 5week - 3month - 6month]
- change of Gynecologic Cancer Lymphedema Questionnaire - Korean (GCLQ-K) score from baseline [Time frame: baseline - 5week - 6month - 12month - 18month - 24month - 36month - 48month - 60month]
- change of Female Sexual Function Index (FSFI) score from baseline [Time frame: baseline - 6month - 12month - 24month - 36month - 48month - 60month]
- length of stay [Time frame: surgery visit]
- transfusion [Time frame: surgery visit]
- hemoglobin decline [Time frame: surgery visit]
- surgery complication [Time frame: surgery visit]
Eligibility criteria
Inclusion criteria
- endometrioid type
- anticipated surgery omitting lymph node dissection for endometrial cancer
- pelvis MRI, CA125 - satisfying KGOG criteria
- no distant metastasis
- age 19 or more
Exclusion criteria
- other cancer within 5 yr
- previous hysterectomy
- previous therapy for endometrial cancer
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-only
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT04227249 · KGOG 3021